Skip to main content
. 2024 Mar 15;17:138. doi: 10.1186/s13071-023-06089-1

Table 7.

Diagnostic accuracy using Bayesian latent class analysis: BLCM model I

Model I Subgroups Median (95% credible interval) (%)
Parasitological technique Prevalence Sensitivity Specificity Positive predictive value Negative predictive value
Direct blood examination (10 µl)/thick blood smear (50 µl) Global 9.7 6.2–13.7 78.9 65.3–90.3 100.0 99.3–100.0 99.1 87.2–100.0 93.0 87.3–97.7
Age group
15–64 years 8.8 5.1–13.0 76.3 62.4–90.0 99.9 99.2–100.0 99.1 86.7–100.0 93.0 87.3–97.7
Other age groupsb
Gender
Male 11.3 5.5–17.7 73.3 56.2–87.3 99.9 98.6–100.0 99.1 86.8–100.0 93.0 87.3–97.6
Female 8.4 4.6–12.6 75.7 61.0–88.9 99.9 99.1–100.0 99.1 86.9–100.0 93.0 87.2–97.6
Symptomatology
Symptomsb
Loiasis-related symptoms 9.1 4.6–14.6 72.3 56.4–87.5 99.9 98.9–100.0 99.1 86.5–100.0 93.0 87.2–97.6
No symptoms 10.2 5.7–15.6 76.1 61.2–89.3 99.9 98.9–100.0 99.1 87.3–100.0 93.0 87.2–97.7
Eosinophilia
Normal 4.5 1.5–8.2 68.7 50.2–85.3 99.9 99.9–100.0 99.1 86.9–100.0 93.0 87.1–97.6
Hypereosinophiliab
Leukoconcentration(5 ml)a Global 9.7 6.2–13.7 99.9 97.8–100.0 91.4 88.6–94.1 74.1 66.0–81.7 99.9 98.8–100.0
Age groups
15–64 years 8.8 5.1–13.0 99.8 97.7–100.0 90.7 87.6–93.5 74.0 66.0–82.1 98.8 98.8–100.0
Other age groupsb
Gender
Male 11.3 5.5–17.7 99.8 97.5–100.0 88.6 84.9–92.3 74.1 65.4–81.7 99.9 98.8–100.0
Female 8.4 4.6–12.6 99.8 97.5–100.0 90.8 87.6–93.6 74.1 66.0–81.9 99.9 98.8–100.0
Symptomatology
Symptomsb
Loiasis-related symptoms 9.1 4.6–14.6 99.8 97.5–100.0 89.1 85.4–92.4 74.1 65.9–81.9 99.9 98.8–100.0
No symptoms 10.2 5.7–15.6 99.8 97.4–100.0 90.1 86.7–93.3 74.1 66.1–82.2 99.9 98.8–100.0
Eosinophilia
Normal 4.5 1.5–8.2 99.8 97.2–100.0 90.2 86.9–93.4 74.1 65.8–81.7 99.9 98.8–100.0
Hypereosinophiliab

aImperfect reference test

bModel did not converge for this particular population subgroup